OBJECTIVE: To present a pooled analysis of the efficacy of rituximab from European cohorts
diagnosed with biopsy-proven lupus nephropathy (LN) who were treated with rituximab. …

Biological agents are increasingly used for a rapidly-expanding number of rheumatic and
systemic autoimmune diseases, with a growing number of reports of the paradoxical induction …

OBJECTIVES: To analyze the clinical characteristics, outcomes, and patterns of association
with the different biologic agents used in all reported cases of adult patients developing …

The emergence of tumor necrosis factor-α (TNF-α)-targeted therapies as a key therapeutic
option for patients with rheumatic, digestive, and dermatologic autoimmune diseases has …

… c) Classification of therapeutic response: due to the heterogeneous clinical presentation
and organ involvement in the different SAD, we used a homogeneous definition for all …

Cryoglobulinemia is characterized by a wide range of causes, symptoms, and outcomes.
Hepatitis C virus (HCV) infection is detected in 30%–100% of patients with cryoglobulins. …

We evaluated the prevalence and clinical significance of cardiovascular risk factors in a
large series of patients with primary Sjögren’s syndrome (SS), focusing on the possible …

… Blood samples were obtained and maintained at 37 C for 30 min before separation. Serum
was prepared by centrifuging at 37 C for 10 min at 2500 rpm. Fresh, centrifugated serum was …

… Maria-Jose Soto-Cardenas, MD, PhD Marta Perez-De-Lis, MD Albert Bove, MD, PhD
Carmen Navarro, MD, PhD Pilar Brito-Zerón, MD, PhD Candido Diaz-Lagares, MD Myriam …

… Soledad Retamozo, MD* Miriam Akasbi, MD* Pilar Brito-Zerón, MD, PhD Xavier Bosch,
MD, PhD Albert Bove, MD PhD Marta Perez-De-Lis, MD PhD Iratxe Jimenez, MD Maria-José …